ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

The system works by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs.

The system has revolutionized how it tests patient blood samples, automating its primary testing facility with high-tech robots that are getting doctors the results they need quickly and efficiently – and allowing UVA to offer a wider range of blood tests, to boot.

Researchers are hoping this icon of artificial intelligence will help people with cancer win as well by providing a rapid, comprehensive report of the genetic mutations at the root of their specific disease and the therapies that target them.

Geneformics Data Systems launches Geneformics D, a cloud compression solution for archiving genomics data.

Researchers corrected the mutation for a heart condition at the earliest stage of embryonic development so that the defect would not be passed on to future generations.